Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor-suppressing gene therapy.

Bingliang Fang1, Jack A Roth

  • 1Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center; Houston, Texas 77030, USA.

Cancer Biology & Therapy
|September 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.

Oncogene·2025
Same author

Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.

The EMBO journal·2025
Same author

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.

Cancer research·2024
Same author

Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers.

Molecular cell·2024
Same author

Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival.

Annals of surgery·2024
Same author

Octreotide's role in the management of post-esophagectomy chylothorax.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2024
Same journal

Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides.

Cancer biology & therapy·2026
Same journal

<i>NSUN2</i> mediates <i>SALL2</i> m5C methylation to inhibit ferroptosis and promote breast cancer progression.

Cancer biology & therapy·2026
Same journal

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy.

Cancer biology & therapy·2026
Same journal

ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinoma.

Cancer biology & therapy·2026
Same journal

Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles.

Cancer biology & therapy·2026
Same journal

Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude <i>versus</i> low-altitude regions: a multi-center retrospective study.

Cancer biology & therapy·2026
See all related articles

Tumor-suppressor gene therapy, particularly using the p53 gene, shows promise in cancer treatment by inducing apoptosis and cell-cycle arrest. Further advancements in gene delivery are needed for broader clinical impact, especially for metastatic diseases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Tumor-suppressor genes are crucial for maintaining genome stability and regulating cell growth.
  • Loss-of-function mutations in these genes are directly linked to cancer development.
  • Gene therapy utilizing tumor-suppressor genes is a rigorously investigated anticancer therapeutic strategy.

Purpose of the Study:

  • To review recent achievements in tumor-suppressor gene therapy.
  • To highlight the role and potential of the p53 gene in cancer treatment.
  • To discuss the challenges and future directions for improving gene replacement approaches.

Main Methods:

  • Review of experimental and clinical research on tumor-suppressor gene therapy.
  • Focus on studies involving direct transfer of tumor-suppressor genes to cancer cells.

Related Experiment Videos

  • Analysis of clinical trial data, particularly for p53 gene therapy.

    • Main Results:

    • Direct gene transfer suppresses tumor growth by inducing apoptosis and cell-cycle arrest.
    • Combination therapy with conventional treatments can yield synergistic effects.
    • Clinical trials with p53 gene therapy show good tolerability and favorable responses in some advanced or resistant cancers.

    Conclusions:

    • Tumor-suppressor gene therapy, especially with p53, is a promising approach with demonstrated clinical benefits.
    • Current gene replacement strategies require improvement for wider clinical application.
    • Development of efficient systemic gene delivery systems is essential for treating metastatic cancers.